McCormick may look inexpensive on one clearly defined earnings measure, but “cheap” is not established by the available figures. At the October 2, 2026 closing quote of $44.60, the shares worked out to about 14.2–14.6 times McCormick’s fiscal 2026 adjusted EPS guidance. That is a calculation from a dated share price and non-GAAP company guidance—not a fair-value estimate. The investment case also depends on modest recent organic growth, the durability of the dividend, and a proposed Unilever Foods transaction that could bring substantial scale and synergies while adding debt, dilution and execution risk.
Is McCormick stock cheap?
The short answer is: possibly on a forward adjusted-earnings basis, but the available figures do not prove the shares are undervalued. MarketBeat’s October 2, 2026 article called McCormick stock cheap and cited roughly 15 times current-year earnings. Its quote widget on the same page showed a P/E of 8.07 without explaining the earnings basis. Those figures are not directly comparable unless their calculation methods are clear.
A more transparent reference point is to divide the October 2 quote of $44.60 by McCormick’s fiscal 2026 adjusted EPS guidance of $3.05–$3.13. The result is approximately 14.2–14.6 times guided adjusted EPS. This calculation uses a dated market quote and company guidance; it is not a GAAP P/E, a prediction of realized earnings or an estimate of intrinsic value. The guidance excludes or adjusts for certain comparability items.
MarketBeat also reported a $55.30 analyst consensus price target and a 4.30% dividend yield in its October 2 context. The target is an analyst consensus figure, not a promised share price or valuation floor. Yield changes with the share price and the dividend rate. Neither figure, by itself, establishes that the stock is a bargain.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
#1 Best Overall
What the valuation case needs to get right
- Use like-for-like earnings: distinguish adjusted EPS from GAAP EPS, and compare the same fiscal period and accounting basis.
- Check earnings quality: determine whether organic sales and operating results can support the earnings used in the multiple.
- Account for the deal: the proposed combination changes ownership, financing and the future earnings profile, so pre-deal metrics do not settle the value of the combined company.
- Treat targets as estimates: analyst expectations are not independent proof of fair value or a guarantee of return.
What McCormick’s latest quarter says about its business
McCormick’s fiscal third quarter of 2026, for the three months ended August 31, showed strong reported growth but considerably slower underlying sales growth. The company said the difference largely reflected the consolidation of McCormick de Mexico. Organic sales exclude acquisitions and currency effects.
| Q3 fiscal 2026 measure | Reported result | Comparison or context |
|---|---|---|
| Net sales | $2,024.8 million | $1,724.9 million a year earlier; reported growth of 17.4% |
| Organic sales growth | 1.9% | Pricing rose 2.2%; volume and mix declined 0.3% |
| McCormick de Mexico contribution | 14.6 percentage points | Contribution to reported sales growth, according to the company |
| Consumer segment | $1,215 million in sales | Sales rose 24.9%; organic sales rose 1.1% |
| Flavor Solutions segment | $809 million in sales | Sales rose 7.7%; organic sales rose 3.0% |
| Gross margin | 39.3% | Up 190 basis points |
| Adjusted operating income | $358.5 million | Up 22.1%; adjusted operating margin expanded 70 basis points to 17.7% |
| Reported operating income | $217.0 million | Down 24.8% |
Those results show why the headline sales increase should not be treated as an equivalent jump in demand. Organic growth was positive, but volume and mix were slightly negative; much of the reported increase came from an acquisition-related contribution. Margin gains and higher adjusted operating income are encouraging, while the gap between reported and adjusted results calls for attention.
Reported earnings and adjusted earnings diverged
McCormick reported Q3 diluted EPS of $0.36, down from $0.84 in Q3 2025. Adjusted diluted EPS was $0.86, compared with $0.85 a year earlier. The company said special charges reduced diluted EPS by $0.50, including transaction and integration costs and a non-cash impairment charge; total Q3 special charges were $141.5 million.
Rank #2
- Ideal for Gifting
- Ideal for a bookworm
- Compact for travelling
For fiscal 2026, the company reaffirmed its outlook for reported net sales growth of 13%–17%, organic sales growth of 1%–3%, adjusted operating-income growth of 16%–20%, and adjusted EPS of $3.05–$3.13. These are management estimates, not guaranteed results. The adjusted figures also should not be confused with GAAP earnings: the quarter illustrates that charges excluded from adjusted measures can materially affect reported results.
Quick wins for a faster PC:
Repair Windows errors before they cause bigger problemsFix Now →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →How strong is the dividend case?
McCormick’s Q3 financial statements show cash dividends paid of $0.48 per share, compared with $0.45 in the year-earlier quarter. For the first nine months of the fiscal year, the respective totals were $1.44 and $1.35. MarketBeat describes the company’s annual dividend-increase history as nearly 40 years. That history is evidence of past increases, not a promise that future increases will continue.
Annualizing four quarterly payments at the Q3 rate produces $1.92 per share. At the October 2 quote of $44.60, that arithmetic corresponds to about 4.3%; it is an annualized calculation, not company guidance about future payments. In April 2026, McCormick’s CEO and CFO said they expected the combined company to maintain dividend payments consistent with McCormick’s history and described a roughly 60% payout ratio. That is management’s stated intention, not a binding commitment.
For an income investor, the dividend’s history and recent payment figures are positives, but the payout should be assessed alongside earnings and financing needs. In particular, the proposed transaction’s cash funding and expected leverage make debt service and the pace of deleveraging relevant to future dividend capacity.
What the proposed Unilever Foods deal means for shareholders
McCormick and Unilever announced their agreement on March 31, 2026. The proposed combination is not complete: McCormick said it expected closing by mid-2027, subject to McCormick shareholder approval, required regulatory approvals and other customary conditions. Its October Q3 release said regulatory filings had been submitted on schedule.
Consideration, ownership and scope
Under the announced terms, Unilever and its shareholders would receive 65.0% of the combined company’s fully diluted equity, in addition to $15.7 billion in cash, subject to closing adjustments. The announcement valued the equity consideration at $29.1 billion using McCormick’s one-month volume-weighted average price of $57.84. It put Unilever Foods’ enterprise value at about $44.8 billion, or 13.8 times fiscal 2025 EBITDA. These are transaction-announcement figures, and the equity value depends in part on the stated share-price reference.
Rank #4
| Expected post-close holder group | Share of combined company |
|---|---|
| Unilever shareholders | 55.1% |
| Current McCormick shareholders | 35.0% |
| Unilever retained interest | 9.9% |
The proposed transaction excludes Unilever’s food business in India, Nepal and Portugal; its Lifestyle & Nutrition business; Buavita; Lipton Ready-to-Drink; and certain other businesses. Readers should therefore understand “Unilever Foods” here as the agreed transaction scope, not every food-related operation or brand associated with Unilever.
Management’s growth and debt projections
McCormick projects that the combined company would have approximately $20 billion in fiscal 2025 revenue and a 21% operating margin. It expects mid- to high-single-digit adjusted EPS accretion in the first 12 months after closing and mid- to high-teens accretion in Year 3. It also forecasts roughly $600 million in annual run-rate cost synergies, net of growth reinvestments and potential dis-synergies, with about two-thirds expected by Year 2. All are management projections, not realized results.
McCormick expects combined-company net leverage of 4.0x or less at closing and intends to reduce it to 3.0x within two years. The cash consideration is expected to be funded with balance-sheet cash and new debt; management has described committed bridge financing. The company says integration planning involves 20 cross-functional teams and more than 200 employees, with transition service agreements intended to support continuity and a phased exit over approximately two years after closing. Those preparations show that planning is underway, but do not establish that the synergy or debt targets will be achieved.
Recommended Free Tools
Best Value
- It can be a gift option
- Comes with secure packaging
- Helpful in various ways
The main arguments for and against the investment
| Potentially favorable case | Counterweight to consider |
|---|---|
| The forward multiple calculated from the dated quote and adjusted EPS guidance is around the mid-teens. | The calculation relies on non-GAAP guidance, while the available P/E figures are not reconciled and no cited independent valuation establishes intrinsic value. |
| Q3 organic sales were positive, gross margin improved, and adjusted operating income increased. | Organic sales growth was far below reported growth, volume/mix declined, and GAAP EPS fell sharply amid special charges. |
| Recent dividend payments were higher year over year, and management has said it expects to maintain payments consistent with McCormick’s history after the deal. | A long increase history and management’s intention do not guarantee future raises; added borrowing and leverage could constrain financial flexibility. |
| The combination could add brands, distribution and scale, with projected synergies and adjusted-EPS accretion. | Current McCormick holders are expected to own a minority of the combined company, and the deal remains conditional. Integration costs, disruption, dis-synergies and failure to realize savings could weaken the expected benefit. |
What to watch before deciding
The investment case is easier to assess if you track a short list of measures rather than relying on the word “cheap” or the deal headline:
- Organic growth and volume/mix: whether underlying sales gains broaden beyond pricing, and how performance differs between Consumer and Flavor Solutions.
- GAAP versus adjusted results: whether special charges persist and whether adjusted earnings translate into reported earnings and cash generation.
- Dividend coverage and leverage: how borrowing costs, debt reduction and the payout interact as the transaction progresses.
- Deal milestones: shareholder and regulatory approvals, closing timing, and eventual results against management’s synergy and accretion forecasts.
- Valuation consistency: use a dated share price and a defined earnings measure, and treat analyst targets as estimates rather than evidence of fair value.
McCormick offers a plausible combination of established dividend growth and a potentially transformative deal, but neither makes the shares automatically cheap or the dividend risk-free. The dated forward adjusted-earnings calculation supports a valuation case worth examining; muted organic growth, the GAAP-adjusted earnings gap, dilution and transaction-related debt are substantial qualifications. Whether the balance is attractive depends on an investor’s confidence in underlying growth and deal execution, as well as tolerance for those risks.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
